ELEVATION OF HEPATOCYTE GROWTH FACTOR CAN INDICATE CARDIAC INVOLVEMENT IN LIGHT CHAIN AND TRANSTHYRETIN AMYLOIDOSIS

Delay in diagnosis of cardiac involvement with amyloidosis (CA) is common predominantly due to nonspecific symptoms and indistinct patterns on non-invasive cardiac testing. An effective serum biomarker may improve early diagnosis of CA. Consecutive patients with light chain (AL) or transthyretin (